Insider · CIK 0001813250

Lavelle Erin M.

Reports to the SEC for 1 company · SEATTLE, WA

Transactions

Companies

Filings

CIK

0001813250

Forms 4 and 5

Insider transactions

2 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-05-11	NGNENeurogene Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2020-06-01	NGNENeurogene Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000

C/O NEOLEUKIN THERAPEUTICS, INC. 360-1616 EASTLAKE AVENUE EAST

SEATTLE, WA, 98102